Where do Taysha Gene Therapies, Inc.'s ratios come from?

Every ratio is computed from Taysha Gene Therapies, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Profitability
Operating margin	-1,130.6%-33.1pp	-1,097.6%-629pp	-468.8%+6,024pp	-6,492.7%—
Net margin	-1,115.3%-43.6pp	-1,071.6%—	——	-6,635.3%—
EBITDA margin	-1,119.6%-36.8pp	-1,082.8%-623pp	-459.8%+5,984pp	-6,443.8%—
Free cash flow margin	-960.1%+19.2pp	-979.2%-482pp	-497.6%—	——
Returns
Return on equity	-68.5%+53.5pp	-121.9%—	——	-344.7%-244pp
Return on assets	-43.3%+10.3pp	-53.6%—	——	-97.6%-23.8pp
Efficiency
Asset turnover	0×0.0×	0.1×-0.1×	0.1×+0.1×	0×—
Liquidity
Current ratio	12.2×+6.8×	5.4×+1.3×	4.1×+2.5×	1.5×-1.5×
Quick ratio	12.2×+6.8×	5.4×+1.3×	4.1×+2.5×	1.5×-1.5×
Cash ratio	12×+6.7×	5.3×+1.4×	3.9×+2.5×	1.4×-1.5×
Leverage
Debt-to-equity	0.3×-0.6×	0.9×+0.1×	0.8×-63.5×	64.3×+64.0×
Debt-to-assets	0.2×-0.2×	0.4×0.0×	0.4×-0.1×	0.5×+0.3×
Interest coverage	-1,753.9×-857×	-896.7×-882×	-14.5×+28.3×	-42.8×+78.6×
Per Share
Book value per share	$0.77+170%	$0.29-55.7%	$0.65+2,888%	$0.02-99.1%
Valuation
Market capitalization	$1.51B+325%	$354.55M+23.0%	$288.17M+160%	$110.97M-71.3%
Enterprise value	$1.26B+350%	$279.07M+35.4%	$206.12M+145%	$84.15M-69.4%
Price / sales	154.2×+112×	42.5×+23.9×	18.7×-25.7×	44.4×—
Price / book	6.1×+1.1×	5×+1.1×	3.8×-113×	116.9×+113×
EV / sales	128.6×+95.1×	33.5×+20.2×	13.3×-20.3×	33.6×—
Free cash flow yield	-6.2%+16.8pp	-23%+3.7pp	-26.7%—	——
Earnings yield	-7.2%+18.0pp	-25.2%—	——	-149.6%-105pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Taysha Gene Therapies, Inc.'s ratios come from?: Every ratio is computed from Taysha Gene Therapies, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.